戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 spital readmissions after kidney, liver, and kidney-pancreas transplantation.
2 ion is safe and effective after simultaneous kidney-pancreas transplantation.
3 hs, and 3 beyond 3 months after simultaneous kidney-pancreas transplantation.
4 ersus-host disease (GVHD) after simultaneous kidney-pancreas transplantation.
5             Of the simultaneous pancreas and kidney, pancreas transplantation alone, and PAK transpla
6          RESULTS.: Simultaneous pancreas and kidney, pancreas transplantation alone, and pancreas aft
7                                              Kidney-pancreas transplantation alters the diabetic mili
8 ent successful pancreas transplantation (108 kidney/pancreas transplantation) and another 28 patients
9 including 18 HNF1B patients receiving SKT or kidney-pancreas transplantation, and in vitro experiment
10 e challenging in the setting of simultaneous kidney-pancreas transplantation, because a reduction in
11 gle kidney transplantation (SKT) or combined kidney-pancreas transplantation can be considered.
12                                     Combined kidney-pancreas transplantation (CKPT) with its associat
13                    Sirolimus (SRL) rescue in kidney-pancreas transplantation has not been well descri
14 A1c 9.1%), nine IDDM patients after combined kidney-pancreas transplantation (HbA1c 5.8%), seven pati
15 ver, there are limited data on how kidney or kidney-pancreas transplantation influence continuous aut
16                                 Simultaneous kidney pancreas transplantation is a safe and effective
17  The aim of this study was to assess whether kidney-pancreas transplantation (KPT) compromises the pr
18  be at high risk and candidates for combined kidney-pancreas transplantation may be monitored more fr
19 cemia in patients with long-standing T1D via kidney-pancreas transplantation or in diabetic mice by t
20 sure decreased to 134/77 mm Hg 1 month after kidney/pancreas transplantation (P<0.001) and decreased
21           To assess the long-term outcome of kidney/pancreas transplantation, patients were identifie
22                  We analyzed 30 simultaneous kidney-pancreas transplantations receiving tacrolimus, m
23                                   Successful kidney/pancreas transplantation results in a marked impr
24 pathy (BKVAN) in the setting of simultaneous kidney-pancreas transplantation (SKPT) has been inadequa
25 yzed 232 patients who underwent simultaneous kidney-pancreas transplantation (SPK) between 1993 and 1
26 tal 28 pancreas transplants (17 simultaneous kidney-pancreas transplantation [SPK], 5 pancreas after
27 idney transplantation (KTx) and simultaneous kidney-pancreas transplantation (SPKTx).
28                             At 1 month after kidney/pancreas transplantation, the average number of a
29 st that, in patients undergoing simultaneous kidney/pancreas transplantation, the entity of dissynchr
30 unosuppressive agents may allow simultaneous kidney-pancreas transplantation to be performed without
31  current standard technique for simultaneous kidney pancreas transplantation usually involves transpl
32             The rate of first fracture after kidney-pancreas transplantation was 12.1% per patient ye
33 and renal failure who underwent simultaneous kidney-pancreas transplantation was found to have stage
34 ls for the first 3 months after simultaneous kidney-pancreas transplantation were 15-20 ng/ml.
35  1994 and December 1, 1998, 147 simultaneous kidney/pancreas transplantations were performed at our c
36 ewed all patients who underwent simultaneous kidney-pancreas transplantation with bladder drainage at
37 c autonomic function follows both kidney and kidney-pancreas transplantation with more pronounced imp
38 lost their pancreas graft after simultaneous kidney-pancreas transplantation with P-E drainage underw

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。